Locoregional versus systemic therapy — robust positive data remain elusive

Locoregional versus systemic therapy — robust positive data remain elusiveLocoregional versus systemic therapy — robust positive data remain elusive, Published online: 01 June 2018; doi:10.1038/s41571-018-0047-6Developments in the treatment of advanced-stage hepatocellular carcinoma include novel locoregional interventions aiming to induce tumour necrosis and systemic treatments targeting the biological mechanisms of tumour progression, thus aiming to delay progression. These approaches fiercely battle to provide the best survival, but their lack of success to date suggests that they might be better tested as a complementary approach.

Source: Nature Clinical Practice Oncology - June 1, 2018 Category: Cancer & Oncology Authors: Marco Sanduzzi-Zamparelli Jordi Bruix Source Type: research